ETOPOPHOS PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Etopophos Preservative Free, and what generic alternatives are available?
Etopophos Preservative Free is a drug marketed by Bristol Myers Squibb and Cheplapharm and is included in two NDAs.
The generic ingredient in ETOPOPHOS PRESERVATIVE FREE is etoposide phosphate. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etoposide phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETOPOPHOS PRESERVATIVE FREE?
- What are the global sales for ETOPOPHOS PRESERVATIVE FREE?
- What is Average Wholesale Price for ETOPOPHOS PRESERVATIVE FREE?
Summary for ETOPOPHOS PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Patent Applications: | 5,596 |
| DailyMed Link: | ETOPOPHOS PRESERVATIVE FREE at DailyMed |
Pharmacology for ETOPOPHOS PRESERVATIVE FREE
| Drug Class | Topoisomerase Inhibitor |
| Mechanism of Action | Topoisomerase Inhibitors |
US Patents and Regulatory Information for ETOPOPHOS PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-002 | Feb 27, 1998 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-001 | Feb 27, 1998 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Cheplapharm | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020457-001 | May 17, 1996 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ETOPOPHOS PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cheplapharm | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020457-001 | May 17, 1996 | ⤷ Subscribe | ⤷ Subscribe |
| Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-002 | Feb 27, 1998 | ⤷ Subscribe | ⤷ Subscribe |
| Cheplapharm | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020457-001 | May 17, 1996 | ⤷ Subscribe | ⤷ Subscribe |
| Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-001 | Feb 27, 1998 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ETOPOPHOS PRESERVATIVE FREE
See the table below for patents covering ETOPOPHOS PRESERVATIVE FREE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| German Democratic Republic | 274423 | VERFAHREN ZUR HERSTELLUNG VON EPIPODOPHYLLOTOXINGLUCOSID-4'-PHOSPHAT DERIVATEN | ⤷ Subscribe |
| Norway | 920277 | ⤷ Subscribe | |
| New Zealand | 225615 | EPIPODOPHYLLOTOXIN GLUCOSIDE 4'-PHOSPHATE AND 4'-PHOSPHOROAMIDATE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS | ⤷ Subscribe |
| Czech Republic | 8805412 | ⤷ Subscribe | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
